168 related articles for article (PubMed ID: 36876496)
1. RNF130 Regulates LDLR Availability and Plasma LDL Cholesterol Levels.
Clifford BL; Jarrett KE; Cheng J; Cheng A; Seldin M; Morand P; Lee R; Chen M; Baldan A; de Aguiar Vallim TQ; Tarling EJ
Circ Res; 2023 Mar; 132(7):849-863. PubMed ID: 36876496
[TBL] [Abstract][Full Text] [Related]
2. Post-translational regulation of the low-density lipoprotein receptor provides new targets for cholesterol regulation.
Aldworth H; Hooper NM
Biochem Soc Trans; 2024 Feb; 52(1):431-440. PubMed ID: 38329179
[TBL] [Abstract][Full Text] [Related]
3. The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOL.
Nelson JK; Sorrentino V; Avagliano Trezza R; Heride C; Urbe S; Distel B; Zelcer N
Circ Res; 2016 Feb; 118(3):410-9. PubMed ID: 26666640
[TBL] [Abstract][Full Text] [Related]
4. The COMMD Family Regulates Plasma LDL Levels and Attenuates Atherosclerosis Through Stabilizing the CCC Complex in Endosomal LDLR Trafficking.
Fedoseienko A; Wijers M; Wolters JC; Dekker D; Smit M; Huijkman N; Kloosterhuis N; Klug H; Schepers A; Willems van Dijk K; Levels JHM; Billadeau DD; Hofker MH; van Deursen J; Westerterp M; Burstein E; Kuivenhoven JA; van de Sluis B
Circ Res; 2018 Jun; 122(12):1648-1660. PubMed ID: 29545368
[TBL] [Abstract][Full Text] [Related]
5. Stable liver-specific expression of human IDOL in humanized mice raises plasma cholesterol.
Ibrahim S; Somanathan S; Billheimer J; Wilson JM; Rader DJ
Cardiovasc Res; 2016 May; 110(1):23-9. PubMed ID: 26786161
[TBL] [Abstract][Full Text] [Related]
6. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
[TBL] [Abstract][Full Text] [Related]
7. Ablation of Plasma Prekallikrein Decreases Low-Density Lipoprotein Cholesterol by Stabilizing Low-Density Lipoprotein Receptor and Protects Against Atherosclerosis.
Wang JK; Li Y; Zhao XL; Liu YB; Tan J; Xing YY; Adi D; Wang YT; Fu ZY; Ma YT; Liu SM; Liu Y; Wang Y; Shi XJ; Lu XY; Song BL; Luo J
Circulation; 2022 Mar; 145(9):675-687. PubMed ID: 35189703
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol-(4,5)-Bisphosphate Regulates Plasma Cholesterol Through LDL (Low-Density Lipoprotein) Receptor Lysosomal Degradation.
Qin Y; Ting F; Kim MJ; Strelnikov J; Harmon J; Gao F; Dose A; Teng BB; Alipour MA; Yao Z; Crooke R; Krauss RM; Medina MW
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1311-1324. PubMed ID: 32188273
[TBL] [Abstract][Full Text] [Related]
9. The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins.
Fischer AW; Albers K; Krott LM; Hoffzimmer B; Heine M; Schmale H; Scheja L; Gordts PLSM; Heeren J
Mol Metab; 2018 Oct; 16():88-99. PubMed ID: 30100244
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.
Goedeke L; Rotllan N; Canfrán-Duque A; Aranda JF; Ramírez CM; Araldi E; Lin CS; Anderson NN; Wagschal A; de Cabo R; Horton JD; Lasunción MA; Näär AM; Suárez Y; Fernández-Hernando C
Nat Med; 2015 Nov; 21(11):1280-9. PubMed ID: 26437365
[TBL] [Abstract][Full Text] [Related]
11. Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor.
Sorrentino V; Zelcer N
Curr Opin Lipidol; 2012 Jun; 23(3):213-219. PubMed ID: 22510808
[TBL] [Abstract][Full Text] [Related]
12. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665
[TBL] [Abstract][Full Text] [Related]
13. NDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation.
Pietiäinen V; Vassilev B; Blom T; Wang W; Nelson J; Bittman R; Bäck N; Zelcer N; Ikonen E
J Cell Sci; 2013 Sep; 126(Pt 17):3961-71. PubMed ID: 23813961
[TBL] [Abstract][Full Text] [Related]
14. Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Promotes Macrophage Activation via LDL Receptor-Independent Mechanisms.
Katsuki S; K Jha P; Lupieri A; Nakano T; Passos LSA; Rogers MA; Becker-Greene D; Le TD; Decano JL; Ho Lee L; Guimaraes GC; Abdelhamid I; Halu A; Muscoloni A; V Cannistraci C; Higashi H; Zhang H; Vromman A; Libby P; Keith Ozaki C; Sharma A; Singh SA; Aikawa E; Aikawa M
Circ Res; 2022 Nov; 131(11):873-889. PubMed ID: 36263780
[TBL] [Abstract][Full Text] [Related]
15. Amino acid starvation-induced LDLR trafficking accelerates lipoprotein endocytosis and LDL clearance.
Chen Y; Wu X; Zhang J; Pan G; Wang X; Guo X; Wang J; Cui X; Gao H; Cheng M; Yang J; Zhang C; Jiang F
EMBO Rep; 2022 Feb; 23(3):e53373. PubMed ID: 34994492
[TBL] [Abstract][Full Text] [Related]
16. Distinct functional domains contribute to degradation of the low density lipoprotein receptor (LDLR) by the E3 ubiquitin ligase inducible Degrader of the LDLR (IDOL).
Sorrentino V; Scheer L; Santos A; Reits E; Bleijlevens B; Zelcer N
J Biol Chem; 2011 Aug; 286(34):30190-9. PubMed ID: 21734303
[TBL] [Abstract][Full Text] [Related]
17. Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression.
Yang JH; Bang MA; Jang CH; Jo GH; Jung SK; Ki SH
J Nutr Biochem; 2015 Nov; 26(11):1393-400. PubMed ID: 26320675
[TBL] [Abstract][Full Text] [Related]
18. Hsa-miR-140-5p down-regulates LDL receptor and attenuates LDL-C uptake in human hepatocytes.
Xu Y; Gao J; Gong Y; Chen M; Chen J; Zhao W; Tan S
Atherosclerosis; 2020 Mar; 297():111-119. PubMed ID: 32109664
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists.
Scotti E; Hong C; Yoshinaga Y; Tu Y; Hu Y; Zelcer N; Boyadjian R; de Jong PJ; Young SG; Fong LG; Tontonoz P
Mol Cell Biol; 2011 May; 31(9):1885-93. PubMed ID: 21343340
[TBL] [Abstract][Full Text] [Related]
20. Platycodin D enhances LDLR expression and LDL uptake via down-regulation of IDOL mRNA in hepatic cells.
Choi YJ; Lee SJ; Kim HI; Lee HJ; Kang SJ; Kim TY; Cheon C; Ko SG
Sci Rep; 2020 Nov; 10(1):19834. PubMed ID: 33199761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
